Allurion Technologies
Update in progressALUR (OTC Markets OTCQB)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Allurion Technologies develops a weight loss platform for overweight individuals in Spain, France, Turkey, and internationally. The Allurion Program includes the Allurion Smart Capsule, a swallowable, procedure-free intragastric balloon, and access to the Allurion Virtual Care Suite, a digital therapeutic combining AI-powered remote monitoring with a behavior-change program. The company is headquartered in Natick, Massachusetts.
Company score
- Sentiment
- -0.30
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- -0.16
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.03
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.16
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketOTC Markets OTCQB (OQB)
- LocationUnited States
- CEODr. Shantanu K. Gaur M.D.
- Employees38
- Websitewww.allurion.com
Identifiers
- ISINUS02008G1022
- FIGIBBG01HPVRLS9
- CIK0001964979